Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features

Fletcher CDM: Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992, 16: 213-228. 10.1097/00000478-199203000-00001

Fletcher CDM, Unni KK, Mertens F, : World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. 2002, Lyon: IARC Press,

Fletcher CDM, van den Berg E, Molenaar WM: Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, 294-296. Lyon: IARC Press,

Fletcher CDM, Gustafson P, Rydholm A, Willén H, Åkerman M: Clinicopathologic re-evaluation of 100 malignant fibrous histtiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001, 19: 3045-3050.

Steiner GC, Jundt G, Martignetti JA: Malignant fibrous histiocytoma of bone. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, 294-296. Lyon: IARC Press,

Mandahl N, Heim S, Arheden K, Rydholm A, Willén H, Mitelman F: Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet. 1988, 30: 23-33. 10.1016/0165-4608(88)90089-1

Shaffer LG, Slovak ML, Campbell LJ: An International System for Human Cytogenetic Nomenclature (2009). 2009, Basel: Karger,

Taubert H, Berger D, Hinze R, Meye A, Würl P, Hogendoorn PCW, Holzhausen H-J, Schmidt H, Rath F-W: How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?. Cancer Lett. 1998, 123: 147-151. 10.1016/S0304-3835(97)00423-0

Tarkkanen M, Larramendy ML, Böhling T, Serra M, Hattinger CM, Kivioja A, Elomaa I, Picci P, Knuutila S: Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridization and c-MYC expression by immunohistochemistry. Eur J Cancer. 2006, 42: 1172-1180. 10.1016/j.ejca.2006.01.035

Bridge JA, Sanger WG, Neff JR, Hess MM: Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis. Pathology. 1990, 22: 16-19. 10.3109/00313029009061420

Örndal C, Mandahl N, Carlén B, Willén H, Wennerberg J, Heim S, Mitelman F: Near-haploid clones in a malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1992, 60: 147-151. 10.1016/0165-4608(92)90007-U

Molenaar WM, van den Berg E, Veth RPH, Dijkhuizen T, de Vries EGE: Tumor progression in a giant cell type malignant fibrous histiocytoma of bone: clinical, radiologic, histologic, and cytogenetic evidence. Genes Chromosomes Cancer. 1994, 10: 66-70. 10.1002/gcc.2870100111

Walter TA, Weh H-J, Schlag PM, Zornig C, Hossfeld DK: Cytogenetic studies in malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1997, 94: 131-134. 10.1016/S0165-4608(96)00220-8

Antonescu CR, Zhang L, Chang N-E, Pawel BR, Travis W, Katabi N, Edelman M, Rosenberg AE, Nielsen GP, Dal Cin P, Fletcher CDM: EWSR1-POU5F1 fusion in soft tissue myoepthelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer. 2010, 49: 1114-1124. 10.1002/gcc.20819

Szuhai K, IJszenga M, de Jong D, Karseladze A, Tanke HJ, Hogendoorn PCW: The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res. 2009, 15: 2259-2268. 10.1158/1078-0432.CCR-08-2184

Carneiro A, Francis P, Bendahl PO, Fernebro J, Åkerman M, Fletcher CDM, Rydholm A, Borg Å, Nilbert M: Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?. Lab Invest. 2009, 89: 668-675. 10.1038/labinvest.2009.18